We are excited to announce that on July 1st, Dorra Pharmaceuticals officially established its first overseas office in Europe. This strategic move marks a significant milestone in our journey towards international growth and enhances our ability to serve the global pharmaceutical market.
The European office will play a crucial role in our commitment to raising the value both for the company and customers. With a strong focus on CDMO and License in/out operations, we are poised to deliver high-quality R&D and production services, driving product upgrades and boosting our competitiveness in the industry.
We are pleased to welcome Dr. Roger Laforce as Managing Director and Mr. Alessandro Gagnoni as Operations Director of Dorra Europe. Their extensive experience and strategic insights will be invaluable as we deepen our presence in the European market and explore new growth opportunities.
As we continue to integrate into the global economy, our European office will serve as a vital bridge, accelerating our international market expansion. We remain dedicated to investing in R&D and technology, providing efficient and high-quality services to our global clients, and maximizing customer value.
Join us in celebrating this exciting development as we forge ahead to become a trusted partner for pharmaceutical companies worldwide.
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 苏ICP备12056923号-1
Tel: 025-82232955 025-82232966
Fax:025-82232933 025-82232944
E-mail: info@dorrapharma.com
